Latest news
October 31, 2006
Debiopharm presents new data confirming anti-HCV activity of cyclophilin inhibitor for Debio-025
October 16, 2006
Debiopharm and Cambridge Antibody Technology enter into an exclusive agreement to develop and market SC-1 for gastric carcinomas
October 11, 2006
Debiopharm and EPFL honour Dr Eduard Batlle with the “Debiopharm Life Sciences Award”
October 2, 2006
The Japanese Cancer Association (JCA) and Debiopharm honour Professors Masanori Hatakeyama and Johji Inazawa with the 2006 JCA-Mauvernay Award
September 21, 2006
Debiopharm granted European Orphan Drugs Status for Debio-0513 (PTR-262) for Myasthenia Gravis
July 24, 2006
Debiopharm applies for first europe marketing authorisation for Sanvar® in France
Stay informed
Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.